Literature DB >> 19805208

Stem cells and a cure for type 1 diabetes?

John A Todd1.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19805208      PMCID： PMC2747152          DOI： 10.1073/pnas.0908373106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  17 in total

1.  What went wrong in the natalizumab trials?

Authors:  Annette Langer-Gould; Lawrence Steinman
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

2.  The habitual, diverse and surmountable obstacles to human immunology research.

Authors:  Adrian C Hayday; Mark Peakman
Journal:  Nat Immunol       Date:  2008-06       Impact factor: 25.606

Review 3.  Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth.

Authors:  Bart O Roep
Journal:  Ann N Y Acad Sci       Date:  2007-03-21       Impact factor: 5.691

4.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

5.  Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Authors:  John T Dimos; Kit T Rodolfa; Kathy K Niakan; Laurin M Weisenthal; Hiroshi Mitsumoto; Wendy Chung; Gist F Croft; Genevieve Saphier; Rudy Leibel; Robin Goland; Hynek Wichterle; Christopher E Henderson; Kevin Eggan
Journal:  Science       Date:  2008-07-31       Impact factor: 47.728

Review 6.  Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization.

Authors:  Peter Achenbach; Jennifer Barker; Ezio Bonifacio
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

Review 7.  Commonality in the genetic control of Type 1 diabetes in humans and NOD mice: variants of genes in the IL-2 pathway are associated with autoimmune diabetes in both species.

Authors:  Dan B Rainbow; Laura Esposito; Sarah K Howlett; Kara M Hunter; John A Todd; Laurence B Peterson; Linda S Wicker
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

8.  Generation of pluripotent stem cells from patients with type 1 diabetes.

Authors:  René Maehr; Shuibing Chen; Melinda Snitow; Thomas Ludwig; Lisa Yagasaki; Robin Goland; Rudolph L Leibel; Douglas A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

Review 9.  Translational mini-review series on type 1 diabetes: Immune-based therapeutic approaches for type 1 diabetes.

Authors:  T Staeva-Vieira; M Peakman; M von Herrath
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

10.  Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.

Authors:  Hsiang-Hsuan Sung; Jyuhn-Huarng Juang; Yu-Chun Lin; Chien-Hung Kuo; Jung-Tung Hung; An Chen; Der-Ming Chang; Sun-Yran Chang; Shie-Liang Hsieh; Huey-Kang Sytwu
Journal:  J Exp Med       Date:  2004-04-12       Impact factor: 14.307
View more
  4 in total

1.  Examination of DNA methyltransferase expression in cloned embryos reveals an essential role for Dnmt1 in bovine development.

Authors:  Michael C Golding; Gayle L Williamson; Todd K Stroud; Mark E Westhusin; Charles R Long
Journal:  Mol Reprod Dev       Date:  2011-04-08       Impact factor: 2.609

2.  Efficacy, safety and influencing factors of intra-calf muscular injection of bone marrow mononuclear cells in the treatment of type 2 diabetes mellitus-induced lower extremity vascular disease.

Authors:  Hui-Min Zhou; Fan Liu; Ai-Ge Yang; Yu-Qing Guo; Ya-Ru Zhou; Yong-Quan Gu; Bao-Yong Yan; Quan-Hai Li
Journal:  Exp Ther Med       Date:  2017-09-22       Impact factor: 2.447

3.  Integration-Free Human Induced Pluripotent Stem Cells From Type 1 Diabetes Patient Skin Fibroblasts Show Increased Abundance of Pancreas-Specific microRNAs.

Authors:  Jun Liu; Mugdha V Joglekar; Huseyin Sumer; Anandwardhan A Hardikar; Halena Teede; Paul J Verma
Journal:  Cell Med       Date:  2014-05-02

Review 4.  Stem cell-based strategies for the treatment of type 1 diabetes mellitus.

Authors:  Yujie Wen; Bo Chen; Suzanne T Ildstad
Journal:  Expert Opin Biol Ther       Date:  2010-11-29       Impact factor: 4.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.